Recruiting
Spirometric Response to Bronchial Thermoplasty in Patients With Severe Asthma
The investigators hypothesis is that there will be improvement in FEV1 in patients with severe asthma. This is a retrospective data study that reviews preexisting medical records; no patients will be enrolled.
ClinicalTrials.gov IDNCT02241265
PhaseNot Applicable
Enrollment20
SponsorUniversity of Oklahoma
Age18 Years
SexALL
Conditions studied
Asthma
About this study
The investigators hypothesis is that there will be improvement in FEV1 in patients with severe asthma. This is a retrospective data study that reviews preexisting medical records; no patients will be enrolled.
Primary outcomes
- The primary endpoints are improvements in prebronchodilator FEV1 and FVC. (1 year after thermoplasty)
Eligibility information
Inclusion Criteria:
* \>18 years of age
* severe asthma diagnosis
* decreased FEV1
Exclusion Criteria:
* \< 18 years of age
Study locations
- OUHSC, Oklahoma City, Oklahoma 73104 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.